• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Processing Research

Processing Research

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function (DGF) after Kidney Transplantation

    Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function (DGF) after Kidney Transplantation

  2. European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)

    European Commission Grants Orphan Drug Designation to SolirisĀ® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)

  3. Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results

    Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results

  4. Gaffney Leaves Loomis Sayles for Crosstown Rival

    PIMCO rolls out a mortgage-related fund, ING renames its greater China fund and alters its strategy, and Goldman Sachs to shut down three emerging-markets single-country funds.

  5. It's Time for PIMCO and Its Fund Board to Step Up

    PIMCO should bring policies in line with its world-class reputation.

  6. It's Time for PIMCO and Its Fund Board to Step Up

    PIMCO should bring policies in line with its world-class reputation.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.